Max Healthcare Institute (MAXHEALTH) Option Chain — Live Strike Data, OI & Greeks

Understanding Max Healthcare's Option Chain

Max Healthcare — India's #2 hospital chain in an aggressive growth phase

Max Healthcare Institute Limited (MAXHEALTH) is India's second-largest listed hospital chain by market capitalisation, after Apollo Hospitals. The company emerged in its current form from the 2018-2019 merger of Max Healthcare and Radiant Life Care under KKR ownership. KKR has since fully exited (August 2022) with a notable 5x return. Three structural facts shape MAXHEALTH's option market in ways that distinguish it from other hospital chains:

• The post-KKR transformation story. KKR acquired a 49.7% stake in the combined Max Healthcare-Radiant entity in 2018 at ₹80 per share. Under Abhay Soi (the turnaround specialist who served as Chairman and Managing Director), the company drove EBITDA margins from 9.7% in FY2019 to 27%+ in subsequent years through pricing optimisation, payer mix improvement, and operational efficiencies. KKR exited fully in August 2022 at ₹353 per share — a 5x return in four years and the largest PE exit in Indian healthcare history. The continued execution post-KKR exit has been a central narrative.
• The aggressive bed expansion plan (FY26-FY28). Max Healthcare plans to add over 3,000 beds between FY26 and FY28 — approximately 2,100 brownfield and 900 greenfield beds — with total capex of ~₹5,700 crore. This will take total capacity from ~5,000 beds to ~8,000+ beds and the total hospital count from 22 to ~30 by 2028. Recent 2024 acquisitions of Lucknow and Nagpur hospitals, plus the Jaypee Hospital Noida ramp-up, are early phases of this expansion. The bed expansion thesis is the central question for the next 3-4 years.
• High-end tertiary and quaternary care focus. Max Healthcare has progressively focused on high-margin tertiary and quaternary procedures — transplants (1,400+ annually), robotic surgeries (5,300+ in FY25 vs 1,000 in FY22), advanced cardiac procedures, oncology, neurosciences. The strategy of moving up the care complexity curve produces higher ARPOB (Average Revenue Per Operating Bed — the key hospital industry metric) and better unit economics than basic/secondary care hospitals.

For option traders, the practical implication is that Max Healthcare's option market is driven by capacity-expansion execution risk and ARPOB trajectory. Quarterly results provide visibility into both, producing material moves on surprises.

How to read Max Healthcare's option chain

Three patterns specific to MAXHEALTH:

• IV expansion around quarterly results. ARPOB growth, occupancy rates, payer mix, and bed expansion progress all produce surprises. Results-day moves of 4-8% are common.
• OI build-up around bed expansion milestones. Each new hospital commissioning, brownfield bed addition, or acquisition closing produces visible OI changes. Pre-milestone positioning based on company guidance is recurring.
• Hospital sector correlation. MAXHEALTH trades partly in sympathy with Apollo Hospitals, Fortis Healthcare, Narayana Hrudayalaya, and other hospital chains on sector-wide news (insurance reforms, government healthcare policy, COVID-style surge events).

What moves Max Healthcare — and its options

Five drivers, in approximate order of impact:

• Quarterly results — ARPOB and occupancy. The single biggest fundamental driver. ARPOB (Average Revenue Per Operating Bed) tracks revenue intensity per bed; occupancy tracks utilisation. Both improving lifts the stock; both weakening pressures it. Max Healthcare reports late July or early August, late October or early November, late January or early February, and mid-May.
• Bed expansion progress. Quarterly disclosure on bed additions, capex execution, and new hospital commissioning. Faster-than-guided expansion lifts the stock; delays pressure it.
• Acquisition activity. Each hospital acquisition (Lucknow, Nagpur, Jaypee Noida ramp-up) provides growth and integration optionality. New acquisition announcements typically lift the stock if priced reasonably.
• Payer mix and insurance reforms. Government insurance (Ayushman Bharat), private health insurance penetration, and direct-pay patient mix all affect Max Healthcare's pricing power. Major insurance reforms (positive or negative) can affect medium-term outlook.
• Hospital sector sentiment. Broad sector rotation, COVID-style surge events, or regulatory news affecting all hospital chains.

MAXHEALTH IV — context for current readings

Max Healthcare's typical implied volatility range is 30-42% in calm market conditions, expanding to 50-65% before quarterly results or around major expansion announcements. This is elevated for a large-cap services stock because of the aggressive growth profile, execution risk on bed expansion, and capacity-utilisation cyclicality. [VERIFY: cross-check IV against the live column.]

How professionals trade Max Healthcare options

Three approaches:

1. Pre-results long volatility. Long straddles 7-10 days before MAXHEALTH results have historically captured larger-than-implied moves because ARPOB and occupancy surprises are common.
2. Pair trades with Apollo Hospitals. When MAXHEALTH diverges meaningfully from Apollo on no obvious stock-specific news, the spread tends to converge during hospital sector rotation periods.
3. Expansion-milestone positioning. Long volatility around scheduled hospital openings or acquisition closings can capture IV expansion. Exit discipline critical.

Common mistakes when trading Max Healthcare options

Underestimating execution risk on bed expansion. Adding 3,000+ beds over three years is operationally complex. Brownfield expansions can face construction delays, regulatory approvals, and ramp-up challenges. Long-dated bullish positions need to factor in execution risk.

Ignoring ARPOB sensitivity. ARPOB growth is the primary value driver for hospital chains. Strategies focused only on overall revenue growth miss the unit economics story.

Treating Max Healthcare like a typical mid-cap. Max Healthcare's high-end tertiary/quaternary care focus, aggressive growth profile, and post-KKR transformation create different dynamics than typical mid-caps. IV regimes and event sensitivities are elevated.

Related tools

• Max Healthcare Max Pain
• Max Healthcare OI Chart
• Max Healthcare Stock Analysis
• Apollo Hospitals Option Chain — peer largest hospital chain
• Fortis Healthcare Option Chain — peer hospital chain
• Sector Analysis — Healthcare sector